Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-[(9S,15S,21S,27S)-27-(4-aminobutyl)-15-benzyl-19-(3-cyclohexylpropanoyl)-9,21-diisobutyl-13-[2-(2-naphthyl)acetyl]-6,11,17,23,29-pentaoxo-25-(3-phenylpropanoyl)-3-thia-7,10,13,16,19,22,25,28-octazabicyclo[28.2.2]tetratriaconta-1(33),30(34),31-trien-7-yl]acetamide
ID: ALA5270104
Max Phase: Preclinical
Molecular Formula: C76H104N10O9S
Molecular Weight: 1333.80
Associated Items: